image: Antibody from a human survivor (light blue) is shown inactivating the Lassa virus surface protein. The work shows how to engineer vaccine strategies to elicit protective immune responses. This material relates to a paper that appeared in the June 2, 2017, issue of Science, published by AAAS. The paper, by K.M. Hastie at The Scripps Research Institute in La Jolla, CA, and colleagues was titled, 'Structural basis for antibody-mediated neutralization of Lassa virus.' view more
Credit: Christina Corbaci, TSRI